コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 reased activity, but not protein content, of glucose 6-phosphate dehydrogenase.
2 ine does not affect the overall structure of glucose 6-phosphate dehydrogenase.
3 sses hexokinase and the rate-limiting enzyme glucose-6-phosphate dehydrogenase.
4 regeneration system and the cytosolic enzyme glucose-6-phosphate dehydrogenase.
5 a role outside of its function in activating glucose-6-phosphate dehydrogenase.
6 ctions based on the molecular model of human glucose-6-phosphate dehydrogenase.
7 red lactate dehydrogenase and heat-denatured glucose-6-phosphate dehydrogenase.
8 aemia, and a mutation of G6PD, which encodes glucose-6-phosphate dehydrogenase.
9 r non-specific glycolytic proteins such as d-glucose-6-phosphate dehydrogenase.
10 ence of 6-aminonicotinamide, an inhibitor of glucose-6-phosphate dehydrogenase.
11 ntapeptide derived from the metabolic enzyme glucose-6-phosphate dehydrogenase.
12 no significant homology with NADP-dependent glucose-6-phosphate dehydrogenases.
13 extensive similarity to an unusual group of glucose-6-phosphate dehydrogenases.
14 ing for cellular NADPH regenerating enzymes (glucose 6-phosphate dehydrogenase, 6-phosphogluconate de
15 ctivity of pentose phosphate pathway enzymes glucose 6-phosphate dehydrogenase, 6-phosphogluconate de
16 ative pentose phosphate pathway (hexokinase, glucose-6-phosphate dehydrogenase, 6-phosphogluconate de
18 oncomitant inhibition of the parasite enzyme glucose-6-phosphate dehydrogenase-6-phosphogluconolacton
19 In P. falciparum , the bifunctional enzyme glucose-6-phosphate dehydrogenase-6-phosphogluconolacton
20 e (70%), phosphoglucose isomerase (65%), and glucose-6-phosphate dehydrogenase (85%), but not phospho
21 ively, decreased TAL expression up-regulated glucose-6-phosphate dehydrogenase activities and GSH lev
23 8 hrs post-PMA injury with a 40% increase in glucose-6-phosphate dehydrogenase activity and a 32% inc
26 rexpression of TAL resulted in a decrease in glucose 6-phosphate dehydrogenase and 6-phosphogluconate
27 reduced levels of TAL resulted in increased glucose 6-phosphate dehydrogenase and 6-phosphogluconate
28 maximal at 72 hrs with an increase of 98% in glucose-6-phosphate dehydrogenase and 346% in 6-phosphog
31 enzymes of human red blood cell metabolism: glucose-6-phosphate dehydrogenase and pyruvate kinase.
32 ations involving conversion to N(tz) ADPH by glucose-6-phosphate dehydrogenase and reoxidation to N(t
34 cids; it overlaps the 5' end of zwf (encodes glucose-6-phosphate dehydrogenase) and is followed immed
35 ed elevations in the mRNAs for malic enzyme, glucose-6-phosphate dehydrogenase, and 6-phosphogluconat
36 blood cell polymorphisms (ie, hemoglobin S, glucose-6-phosphate dehydrogenase, and alpha-thalassemia
37 n of branched-chain keto acid dehydrogenase, glucose-6-phosphate dehydrogenase, and amidase in both s
38 three enzymes (catechol-O-methyltransferase, glucose-6-phosphate dehydrogenase, and glyceraldehyde-3-
39 ), oxidative stress (glutathione peroxidase, glucose-6-phosphate-dehydrogenase, and ascorbate peroxid
40 , a plasma membrane (PM) marker; activity of glucose-6-phosphate dehydrogenase, assayed as cytosolic
41 h the construction of the molecular model of glucose-6-phosphate dehydrogenase, based on the structur
42 A1 substantially reduced the inactivation of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal
43 as exemplified for the reaction catalyzed by glucose-6-phosphate dehydrogenase by comparing the 1-(13
44 eric molecular mass of 33.8kDa while that of glucose-6-phosphate dehydrogenase (D-glucose 6-phosphate
45 acute haemolytic anaemia in individuals with glucose-6-phosphate dehydrogenase deficiency (G6PDd).
47 [95% confidence interval {CI}, 0.52-0.90]), glucose-6-phosphate dehydrogenase deficiency in female c
49 lasmic PICD, the phenotypes of patients with glucose-6-phosphate dehydrogenase deficiency suggest tha
50 lpha-thalassemia, 0.3%; ABO group, 0.3%; and glucose-6-phosphate dehydrogenase deficiency, 0.5%) and
51 tors for neurotoxicity, such as prematurity, glucose-6-phosphate dehydrogenase deficiency, or hypoxia
53 No correlation with sickle cell trait or glucose-6-phosphate-dehydrogenase deficiency was observe
55 splantation studies in cats heterozygous for glucose-6-phosphate-dehydrogenase, different estimates o
60 d sex-specific QTL underlying differences in glucose-6-phosphate dehydrogenase enzyme activity betwee
62 ith uncomplicated falciparum malaria, normal glucose-6-phosphate dehydrogenase enzyme levels, and hem
63 either 6PGD or another oxidative PPP enzyme, glucose-6-phosphate dehydrogenase, exhibit non-immune he
64 a substrate for an enzyme, F(420)-dependent glucose-6-phosphate dehydrogenase (Fgd), found in few ba
65 The gene fgd, which codes for F420-dependent glucose-6-phosphate dehydrogenase (FGD), was cloned from
67 most commonly mediated by loss of a specific glucose-6-phosphate dehydrogenase (FGD1) or its deazafla
68 of Asp-177 in the His-Asp catalytic dyad of glucose 6-phosphate dehydrogenase from Leuconostoc mesen
70 A large excess of ALDH3A1 also protected glucose-6-phosphate dehydrogenase from inactivation beca
73 immunofluorescence microscopy has shown that glucose-6-phosphate dehydrogenase (G-6-PDase), the rate-
74 tatus of mitochondrial glutathione (GSH) and glucose 6-phosphate dehydrogenase (G6-PD) was restored b
75 -yl)-2,5-diphenyltetrazolium bromide] (MTT), glucose-6-phosphate dehydrogenase (G6DP), and calcein AM
76 Salmonella typhimurium zwf mutants lacking glucose 6-phosphate dehydrogenase (G6PD) activity have i
78 m embryonic stem cells in which the X-linked glucose 6-phosphate dehydrogenase (G6PD) gene had been t
80 autologous marrow transplantation studies of glucose 6-phosphate dehydrogenase (G6PD) heterozygous fe
81 ession of a thoroughly characterized enzyme: glucose 6-phosphate dehydrogenase (G6PD) in human erythr
84 inactivating ATM or its downstream effector glucose 6-phosphate dehydrogenase (G6PD) sensitizes AML
85 gnment of the amino acid (aa) sequence of 52 glucose 6-phosphate dehydrogenase (G6PD) species from 42
86 0 from the 109 kDa Leuconostoc mesenteroides glucose 6-phosphate dehydrogenase (G6PD) were assigned b
89 ation and isocitrate dehydrogenase (IDH) and glucose-6-phosphate dehydrogenase (G6PD) activities are
90 riation in isocitrate dehydrogenase (IDH) or glucose-6-phosphate dehydrogenase (G6PD) activity in a s
96 d on the oxidation of G6P in the presence of glucose-6-phosphate dehydrogenase (G6PD) and nicotinamid
97 atty acids inhibit the expression of hepatic glucose-6-phosphate dehydrogenase (G6PD) by changes in t
98 reduction of NADPH generation via a block of glucose-6-phosphate dehydrogenase (G6PD) by treatment wi
99 .-) production, suggesting that intranuclear glucose-6-phosphate dehydrogenase (G6PD) can control NOX
100 s study investigates the significance of the glucose-6-phosphate dehydrogenase (G6PD) catalyzed oxida
101 mutations of the housekeeping gene encoding glucose-6-phosphate dehydrogenase (G6PD) cause G6PD defi
102 out dose-dependent haemolysis in people with glucose-6-phosphate dehydrogenase (G6PD) deficiencies ha
103 ), alpha thalassaemia, ABO blood groups, and glucose-6-phosphate dehydrogenase (G6PD) deficiency enco
111 omplicated by haemolysis in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency.
112 l malaria risk factors, and we also assessed glucose-6-phosphate dehydrogenase (G6PD) enzyme activity
116 2) IL-1beta stimulated increased activity of glucose-6-phosphate dehydrogenase (G6PD) in a time- and
117 s in mitochondria, whereas chloroquine and a glucose-6-phosphate dehydrogenase (G6PD) inhibitor affec
127 hrough microscopy and had normal function of glucose-6-phosphate dehydrogenase (G6PD) on colorimetric
128 , which was exacerbated in erythrocytes from glucose-6-phosphate dehydrogenase (G6PD) patients and re
133 t of reductive capacity by overexpression of glucose-6-phosphate dehydrogenase (G6PD), a key enzyme f
134 y (PPP) is necessary for NET release because glucose-6-phosphate dehydrogenase (G6PD), an important e
136 ented expression and enzymatic activities of glucose-6-phosphate dehydrogenase (G6PD), glutathione re
137 ene expression of GLUT1 glucose transporter, glucose-6-phosphate dehydrogenase (G6PD), superoxide dis
139 the bacterial pathogen Pseudomonas syringae Glucose-6-phosphate dehydrogenase (G6PD), the key enzyme
142 ose phosphate pathway through the actions of glucose-6-phosphate dehydrogenase (G6PD), the rate-limit
144 the activity of another cytoplasmic enzyme, glucose-6-phosphate dehydrogenase (G6PD), was also measu
146 ne deacetylase (HDAC) inhibitors (HDACis) in glucose-6-phosphate dehydrogenase (G6PD)-deficient cells
151 lucose uptake with a concomitant increase in glucose-6-phosphate dehydrogenase (G6PDH) activity, the
152 eveloped by using a coupled enzyme system of glucose-6-phosphate dehydrogenase (G6PDH) and bacterial
153 investigated the reactivation of aggregated glucose-6-phosphate dehydrogenase (G6PDH) by ClpB and it
157 toxification enzymes such as NQO1 as well as glucose-6-phosphate dehydrogenase (G6PDH), a regulator o
158 he Pseudomonas aeruginosa zwf gene, encoding glucose-6-phosphate dehydrogenase (G6PDH), an enzyme tha
159 linked isocitrate dehydrogenase (NADP-ICDH), glucose-6-phosphate dehydrogenase (G6PDH), and, glutathi
160 showed here that a mutation in zwf, encoding glucose-6-phosphate dehydrogenase (G6PDH), leads to a ap
165 athione (GSH), glutathione peroxidase (GPX), glucose 6-phosphate dehydrogenase, glutathione reductase
166 ant enzymes including alcohol dehydrogenase, glucose 6-phosphate dehydrogenase, glycerol 3-phosphate
167 ontinuous assay, using glucokinase (Glk) and glucose-6-phosphate dehydrogenase (Gpd) from Thermotoga
170 viously studies using X-linked genes such as glucose-6-phosphate dehydrogenase have been handicapped
171 sis of autologous transplantation studies in glucose-6-phosphate dehydrogenase heterozygous cats to d
173 Here we report point mutations in the human glucose-6-phosphate dehydrogenase (hG6PD) gene transferr
174 The frequencies of low-activity alleles of glucose-6-phosphate dehydrogenase in humans are highly c
175 hibition of the pentose phosphate pathway by glucose-6-phosphate dehydrogenase inhibitors and siRNA s
176 e of the bacterial Leuconostoc mesenteroides glucose-6-phosphate dehydrogenase, it has been possible
177 , mRNAs for several other lipogenic enzymes (glucose-6-phosphate dehydrogenase, malic enzyme, glycero
179 strate and coenzyme binding and catalysis of glucose-6-phosphate dehydrogenase of Leuconostoc mesente
180 e did not observe changes in the activity of glucose-6-phosphate dehydrogenase or in the pentose phos
181 stroy the tissues to study the haplotypes of glucose-6-phosphate dehydrogenase or to determine the re
184 ococcal mutants deficient in PavA, CodY, and glucose-6-phosphate dehydrogenase pointing to the robust
186 ependence of the kinetic parameters of D177N glucose 6-phosphate dehydrogenase results from an ionize
188 eveloped by utilizing a "wired" thermostable glucose-6-phosphate dehydrogenase (tG6PDH) from the hype
189 Mycobacterium smegmatis was found to have a glucose-6-phosphate dehydrogenase that was dependent on
190 ibrosis transmembrane conductance regulator, glucose-6-phosphate dehydrogenase, the neural cell adhes
191 -1 but no changes in glutathione peroxidase, glucose-6-phosphate dehydrogenase, thiols, or catalase.
192 ecific inhibitor (dehydroepiandrosterone) of glucose-6-phosphate dehydrogenase together established r
193 nternal control was shown by comparison with glucose-6-phosphate dehydrogenase transcript levels in 1
195 The three-dimensional structure of the H240N glucose 6-phosphate dehydrogenase was determined at 2.5
196 smutase 1, glutathione S-transferase-pi, and glucose-6-phosphate dehydrogenase was unaffected by cast
197 peroxidase, NADH/NADP+ transhydrogenase, and glucose-6-phosphate dehydrogenase were most strongly ind
198 of the cytosolic isocitrate dehydrogenase or glucose-6-phosphate dehydrogenase, which also produce cy
199 ersensitivity to SFK2 yielded ZWF1, encoding glucose-6-phosphate dehydrogenase, which has been shown
200 strain over-expressing zwf gene (coding for glucose-6-phosphate dehydrogenase), WX-zwf, produced the
201 own previously to require function of either glucose-6-phosphate dehydrogenase (ZWF1) or cytosolic NA
202 ted an investigation of mutants defective in glucose-6-phosphate dehydrogenase (Zwf1), which catalyze
203 ells grown on glucose has been attributed to glucose-6-phosphate dehydrogenase (Zwf1p) and a cytosoli
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。